As artificial intelligence infrastructure expands at pace, the insurance risks surrounding global data centres are growing increasingly complex and harder to manage. Large lawsuits involving data centres more than tripled from four
The Consumer Product Safety Commission is significantly expanding its capacity to detect consumer product-related injuries through a major overhaul of its surveillance infrastructure. Acting Chairman Peter Feldman announced the updated National Electronic
More
New Jersey’s highest court has approved a sweeping ethics rule prohibiting attorneys from engaging in sexual relationships with their current clients. The rule replaces the state’s long-standing case-by-case approach to such conduct
More
GE Vernova has emerged as one of the most closely watched energy transition stocks on Wall Street, with analysts pointing to a compelling multi-year growth runway. The company, spun out of General
More
Investors searching for reliable income from the UK stock market have increasingly turned their attention to FTSE 250 companies offering sustained and well-covered dividend yields. A yield of around 7% is considered
More
GSK has secured its first-ever lung cancer drug approval after the US Food and Drug Administration cleared Jideytro, delivering a rapid return on the company’s major acquisition. The FDA approved the drug
More
House Judiciary Chair Jim Jordan has sent a criminal referral to the Department of Justice accusing former Special Counsel Jack Smith of lying under oath before the committee. Jordan alleged that Smith
More
Hardide (LSE: HDD) has delivered one of the most extraordinary runs of any UK-listed stock over the past twelve months, rising more than 1,150%. The surface coatings specialist has surged 455% in
More
Equity markets delivered a mixed performance as a pause in rising oil prices offered little relief to investors already watching bond yields hover near recent highs. The divergence across global indices reflected
More
BP is closing in on a deal to sell its solar power arm to an investor consortium backed by Kuwait’s sovereign wealth fund, marking another step away from renewables. Private equity firm
More
Novo Nordisk has escalated its legal fight against Eli Lilly, notifying a federal court of plans to seek a preliminary injunction blocking certain rival obesity drug advertisements. The Danish pharmaceutical giant filed
More